The human ABCG2 multidrug transporter actively extrudes a wide range of hydrophobic drugs and xenobiotics recognized by the transporter in the membrane phase. In order to examine the molecular nature of the transporter and its effects on the lipid environment, we have established an efficient protocol for the purification and reconstitution of the functional protein. We found that the drug-stimulated ATPase and the transport activity of ABCG2 are fully preserved by applying excess lipids and mild detergents during solubilization, whereas a detergent-induced dissociation of the ABCG2 dimer causes an irreversible inactivation. By using the purified and reconstituted protein we demonstrate that cholesterol is an essential activator, whereas bile acids are important modulators of ABCG2 activity. Both wild-type ABCG2 and its R482G mutant variant require cholesterol for full activity, although they exhibit different cholesterol sensitivities. Bile acids strongly decrease the basal ABCG2-ATPase activity both in the wild-type ABCG2 and in the mutant variant. These data reinforce the results for the modulatory effects of cholesterol and bile acids of ABCG2 investigated in a complex cell membrane environment. Moreover, these experiments open the possibility to perform functional and structural studies with a purified, reconstituted and highly active ABCG2 multidrug transporter.
INTRODUCTION
ABC (ATP-binding cassette) multidrug transporters actively extrude several toxic, chemically non-related and mostly hydrophobic compounds from the cell [1] . The ABCG2 protein, due to its wide substrate specificity and localization in important tissue barriers, is an important member of the chemical defence network and also has a significant role in cancer multidrug resistance [1, 2] . A detailed characterization of the human ABCG2 transporter has been hindered by the lack of efficient isolation and purification methods. Both direct molecular interaction experiments and structural studies at the atomic level, e.g. crystallization of the purified protein, require a fully functional purified ABCG2 protein. Several reports have been published describing the purification of a recombinant human ABCG2 protein either from Sf9 cells or Saccharomyces cerevisiae. However, the activity of the purified and reconstituted ABCG2 was relatively low, as compared with the transporter investigated in a complex membrane environment [3] [4] [5] .
The lipid composition and the physical state of the plasma membrane are known to influence the activity of many transporter proteins. In the case of ABCG2, we and others have shown previously that, in an original cell membrane environment, cholesterol is an important activator of ABCG2 function [6] [7] [8] , by increasing both substrate-stimulated ATPase activity and direct vesicular substrate transport. Our previous study also showed that some Arg 482 mutant variants of ABCG2 are not only substrate mutants but also exhibit altered cholesterol sensitivity [8] . We have also found previously that, in insect cell membranes, high drug-independent basal ABCG2 ATPase activity is strongly reduced by bile acids, whereas these compounds have little effect on the drug-stimulated ATPase activity (Á. Telbisz and Cs.Özvegy-Laczka, unpublished work).
In order to examine the mechanism of the transporter and the effects of the lipid environment, and also for providing a proper reagent for crystallization trials, we carefully optimized the purification and reconstitution procedures for the ABCG2 protein. In the present study we describe a method for an efficient purification of a fully active ABCG2 protein, as well as a detailed characterization of the effects of membrane lipids, cholesterol and bile acids on this transporter. We have reconstituted the purified wild-type and the ABCG2-R482G variant into liposomes with different lipid compositions, and evaluated the effects of mutations on the cholesterol and bile acid sensitivity of these transporter variants.
EXPERIMENTAL

Materials
Most of the materials were obtained from Sigma-Aldrich, apart from where indicated. Lipid preparations were obtained from Avanti Polar Lipids.
http://www.biochemj.org/bj/450/bj4500387add.htm). To create an only His-tagged protein, we removed the BamHI fragment encoding ABCG2 equipped with an N-terminal His 6 -tag, but without GST from the pAcGHLT-B/wtABCG2 vector and ligated it between the BglII sites of the pAcUW21-L vector [10] . The His 6 -tagged ABCG2-R482G mutant was created by cloning the PstI/SacI fragment of pAcUW21-L/ABCG2-R482G into the pAcUW21-L/His 6 -wtABCG2 vector.
Culture and viral infection of Sf9 cells
Culturing conditions were optimized for high expression levels of membrane proteins in Sf9 cells. Cells were cultured in spinner flasks, but baculovirus infection was carried on in surfaceattached cells in a slowly (approximately 20 rev./min) rolling bottle [3×10 8 cells/100 ml TNM-FH medium supplemented with 10 % (v/v) fetal bovine serum] and infected by baculovirus [20 ml of amplified stock, 1-2×10 8 pfu (plaque-forming units)/ml]. Crude membrane was prepared from harvested cells on the third day of infection as described previously [10] . Briefly, cells were washed in a hypotonic buffer [50 mM Tris, 50 mM mannitol and 2 mM EGTA, pH 7.0, containing protease inhibitors: 8 μg/ml aprotinin, 10 μg/ml leupeptin, 0.5 μg/ml PMSF and 2 mM DTT (dithiothreitol)] and disrupted mechanically in a glass-teflon homogenizer. The preparation was centrifuged at low speed (200 g, 10 min) and membrane vesicles were collected by ultracentrifugation of the supernatant in a second step (180 000 rev./min, 60 min in a Beckman JA-20 rotor). Crude membrane was stored at − 80
• C.
Solubilization and purification of ABCG2
Crude Sf9 cell membrane preparations were washed in highsalt buffer (5 mM EDTA, 500 mM NaCl and 20 mM Tris, pH 8.0). Solubilization of membrane proteins was achieved in a lipid/detergent mixture [1 % (w/v) DDM (dodecyl maltoside), 0.4 % Escherichia coli lipid extract (Avanti Polar Lipids, 100 500), 500 mM NaCl, 4 mM imidazole, 10 % (v/v) glycerol, 1 mM 2-mercaptoethanol and protease inhibitors in 20 mM Tris, pH 8.0] at a 2.5 mg/ml protein concentration for 60 min at 4 • C. Solubilized membrane proteins were cleared by ultracentrifugation and the His 6 -tagged ABCG2 protein was purified by batch purification using Ni-NTA (Ni 2 + -nitrilotriacetate; Sigma His-select, H-0537). After overnight binding of the protein, Ni-NTA beads were washed first by high (500 mM NaCl)-and then low (30 mM NaCl)-salt buffers. Bound protein was eluted by 250 mM imidazole. All washing and elution buffers contained 0.01 % DDM, 10 % (v/v) glycerol and 1 mM 2-mercaptoethanol. Eluted fractions were collected and analysed for ABCG2 and total protein content. Optionally, the eluted fractions were concentrated by an Amicon 100 kDa centrifugal filter unit and stored at − 80
ABCG2 reconstitution in liposomes
The various experimental lipid reconstitution conditions are detailed in the Results section. Transport-competent liposomes were prepared from brain lipid extract (Avanti Polar Lipids, 131101C) and cholesterol (Avanti Polar Lipids, 13580) in a 5:1 weight ratio. Lipids were dried from chloroform solution under an argon stream, freeze-dried for 1 h and resuspended in 150 mM NaCl and 5 mM Tris, pH 7.5. The final lipid concentration was 24 mg/ml. Liposomes were homogenized by extrusion (400 nm filter), aliquoted (1 ml, snap frozen in liquid N 2 and stored at − 80 • C.
Liposomes were destabilized with 0.3 % Triton X-100 for 30 min at 20
• C. The desalted ABCG2 sample was mixed with liposomes at a 1:6 mass ratio and allowed to reconstitute for 2 h at 20
• C with gentle agitation. Excess detergent was removed by SM2 biobead adsorbent (Bio-Rad Laboratories) in several rounds. Finally, samples were centrifuged at 186 000 g for 20 min and resuspended in 10 mM Hepes, pH 7.5, containing 50 mM KCl. ABCG2 proteoliposome samples were aliquoted (20 μl) , snap frozen and stored at − 80
Protein quantification
The amount of protein in fractions eluted from the Ni-NTA affinity column was estimated on the basis of Coomassie Blue staining of the SDS/PAGE gel after electrophoresis, in comparison with a serum albumin standard set. For more precise quantification, a modified Lowry method was applied [11] .
SDS/PAGE and Western blotting
Eluted fractions of affinity purification were analysed after trichloroacetic acid precipitation and disaggregation in an SDS sample buffer. For the detection of ABCG2 dimers using Western blotting, we incubated purified ABCG2 either with oxidized DTT (2 mM) or the protein cross-linker BM(PEO) 3 (1,8-bismaleimidotriethyleneglycol) (1 mM, Pierce) for 20 min at 37 • C. Samples were then diluted in SDS sample buffer without 2-mercaptoethanol [12] .
ATPase activity measurements
Purified ABCG2 (0.1 μg in a 5-10 μl volume) was mixed with 0.5-1 mg/ml of preformed liposomes (in a 140 μl volume) and incubated for 20 min at 37
• C. The relative amounts of the lipids specified in the Results section are calculated as mol % by estimating the average molar mass of E. coli lipid as 730-740 g/mol. By this simplified reconstitution protocol, the DDM detergent is diluted below 0.0 007 % in proteoliposome preparation, which does not disturb ABCG2 functionality. The measurement of ATPase activity was then started by addition of 3.3 mM MgATP and reaction was allowed to run for 30 min before termination by 2 % (w/v) SDS. Inorganic phosphate derived from ATP hydrolysis was determined by colorimetric reaction as described for cell membrane vesicle preparations [11] .
Methotrexate transport measurements
ABCG2 proteoliposome (2 μg of ABCG2/sample) was incubated with a mixture of unlabelled and radiolabelled methotrexate ([ 3 H]methotrexate, Moravek; total concentrations are indicated in the Results section) for 10 min at 37
• C. The transport capacity of ABCG2 was measured using a rapid filtration method and scintillation counting of samples was performed as described previously [13] .
Statistical analysis
All experiments were performed at least in three independent measurements and the + − S.D. values are shown on the graphs. Significance was determined by the Student's t test at P < 0.01.
RESULTS
Purification of functional human ABCG2
For affinity purification of the human ABCG2 protein, we generated an N-terminally His 6 -tagged ABCG2 (Supplementary Figure S1 ) and expressed it in Sf9 insect cells. The expression of the His 6 -tagged ABCG2 was examined by Western blotting, using both the ABCG2-specific antibody BXP-21 (Supplementary Figure S2 at http://www.biochemj.org/bj/450/bj4500387add.htm) and the anti-His-tag antibody (results not shown). The Western blots showed that the tagged protein was expressed at a similar level as the non-tagged version. Moreover, the His 6 -modified ABCG2 showed a similar activity in membrane preparations as the non-tagged protein (Supplementary Figure S2) .
In the course of the purification of transporter proteins, membrane solubilization is a critical step. In order to find the optimum conditions that preserve the activity of the transporter, we examined numerous detergents and conditions (e.g. various detergent and protein concentrations, different extraction times and lipid additives), and assayed both the extracted protein yield (by SDS/PAGE) and activity (ABCG2 ATPase measurements) for each condition. Since the ABCG2 ATPase activity was negligible in detergents (see below), activity measurements required an additional lipid reconstitution step in each case. Finally, the substrate stimulation of the ABCG2 ATPase was examined and the whole process was iteratively refined.
For Sf9 membrane solubilization we tested several commonly used detergents, including FC-16 (Fos-choline-16), DDM and CHAPS, and analysed the solubilization capacity of these detergents in ABCG2-containing Sf9 cell membrane fractions by SDS/PAGE and Western blotting. We found that 1 % (w/v) FC- Soluble proteins were cleared by ultracentrifugation and the ABCG2 protein was purified by affinity binding of the polyhistidine-tag to Ni-NTA beads (as detailed in the Experimental section). The purity of the eluted fractions was examined by SDS/PAGE and Western blotting ( Supplementary Figure S2 , right-hand panel). As has been described previously [4] , a significant amount of ABCG2 (approximately 5 %; results not shown) was unable to bind to Ni-NTA, possibly because of lipids masking the tag. The fractions eluted from the affinity column by imidazole containing the ABCG2 protein were kept solubilized in 0.01 % DDM (and the remaining lipids), optionally concentrated, and stored at − 80
• C. Under these conditions the solubilized and purified ABCG2 protein was stable for several months.
Interestingly, we found that the ABCG2 protein was inactive in the detergent-solubilized form in each case. However, we observed that in some cases the protein regained its ATPase activity after a brief preincubation with preformed liposomes (E. coli lipid with at least 20 mol % cholesterol, see below). The ATPase activity of the purified and reconstituted ABCG2 was very low after the use of any of the applied detergents, but could be preserved when excess lipid (0.4 % E. coli total lipid extract) was used together with 1 % (w/v) DDM in the solubilization step ( Figure 1A ). This notion was based on a protocol previously used for the purification of active P-glycoprotein [14] . Still, when the FC-16 detergent and the above lipid extract were applied, although ABCG2 solubilization was efficient, the ATPase activity was abolished.
Since ABCG2 is only active as a homodimer [15] , we examined the oligomerization state of the ABCG2 protein after purification. We investigated the ability of purified ABCG2 to form S-S bridge linked homodimers (present in physiological conditions) or the capability of a previously described chemical cross-linker to covalently link the two ABCG2 monomers (see [12, 15] ). Other parameters were identical throughout the purification and reconstitution in both cases. E. coli lipid extract (0.4 %) was present in both of the solubilization buffers. ABCG2 protein concentration of purified samples was determined by Coomassie Blue staining after SDS/PAGE and was similar in both preparations (inset). After purification we reconstituted ABCG2 protein in lipids (E. coli lipid with 30 mol % cholesterol) in a similar manner. ATPase activity was determined in the presence of sodium orthovanadate (Van.; 1 mM) in the absence (basal activity) and presence of a substrate, quercetin (Quer.; 5 μM). M, molecular masses of proteins with values in kDa. (B) Examination of the dimerization state of purified ABCG2 after solubilization with different detergents. Purified ABCG2 after FC-16 or DDM solubilization in reduced samples (as a control) and in samples treated with oxidized (ox.) DTT or BM(PEO) 3 was subjected to SDS/PAGE and Western blotting. ABCG2 was visualized using the BXP-21 antibody. The samples contained approximately equal amounts of the Ni-NTA purified protein (as detailed in the Experimental section). Molecular masses in kDa are indicated to the left-hand side.
Treatment of the membranes containing ABCG2 by oxidized DTT or cross-linkers such as BM(PEO) 3 before SDS/PAGE has been reported to preserve the ABCG2 dimer, which could be identified by its lower mobility on the polyacrylamide gel. The Western blot in Figure 1 (B) demonstrates that the oxidation-dependent dimer formation of the purified ABCG2 was preserved in the case of the DDM plus lipid-solubilized protein preparation, whereas this dimerization could not be observed in the case of the FC-16 plus lipid-extracted protein preparation. A similar dimerization could be observed of the DDM plus lipid, but not in the FC-16 plus lipid-purified protein sample when the cross-linker BM(PEO) 3 was added to the preparation. These data suggest that ABCG2 dimers irreversibly dissociate in the upon application of FC-16, resulting in a strongly reduced activity.
Characterization of the activity of purified and reconstituted wild-type ABCG2
Basic features of ABCG2-ATPase activity
The activity of the ABCG2 transporter protein can be examined as a specific (vanadate-and Ko143-sensitive) ATP hydrolysis.
In cell membrane vesicles ABCG2 has a relatively high basal activity, which, in an appropriate membrane environment, can be significantly stimulated by transported substrates of the protein (e.g. quercetin, nilotinib or prazosin). In order to find the best conditions for obtaining an active transporter we examined the effect of reconstitution in liposomes with various lipid contents. For the examination of the ATPase activity a simplified reconstitution protocol was used, where concentrated, purified and detergent-solubilized ABCG2 was pre-incubated with preformed liposomes for a short time. This enables the reconstitution of proteoliposomes while the detergent is diluted to a negligible level (as detailed in the Experimental section).
As mentioned above, the ATPase activity of the purified ABCG2 protein was negligible without reconstitution. When the ABCG2 protein was reconstituted in liposomes containing an E. coli lipid extract, a significant vanadate-sensitive basal ATPase activity was detected, but substrate stimulation was negligible. Since ABCG2 activity requires the presence of cholesterol, which is not present in the E. coli lipid extract, we added various amounts of cholesterol to the E. coli lipid reconstitution system. As shown in Figure 2 (A), in an optimal E. coli lipid/cholesterol mixture the basal ABCG2 ATPase activity was slightly increased, whereas the drug-stimulated ATPase activity reached a high level. When a natural lipid extract from mammalian brain was used as a reconstitution material, both the basal and substrate-stimulated ATPase activities were high, similarly to that obtained in the E. coli lipids plus cholesterol mixture. Interestingly, we detected a significantly lowered ATPase activity of ABCG2 in liposomes containing soya bean (or egg) phosphatidylcholine (shown in Figure 2A ), or a mixture of phosphatidylcholine and phosphatidylethanolamine, dioleyl-or distearyl-phosphatidylcholine (results not shown), even if various amounts of cholesterol were added to the mixture. The exact lipid ratio of the applied natural lipid extracts (Avanti Polar Lipids) is not defined by the company, therefore the specific role of the individual lipid components could not be clarified in the present study.
Previously we found that, in the original cell membrane environment, cholesterol had the highest capacity to activate the transporter and other sterols were less effective in this regard [8] . Similarly, by using the cholesterol-free E. coli lipid extract supplemented with various sterols, we found that, in the case of the isolated ABCG2, cholesterol was the most efficient at promoting drug-stimulated ABCG2 ATPase activity ( Figure 2B ). However, other sterols, including ergosterol and sitosterol, could replace cholesterol to some extent, especially at higher concentrations.
In the experiments of the present study, under optimum purification and reconstitution conditions (see Figure 2A) , the activity of the ABCG2 ATPase was 2-4 μmol P i /min per mg of ABCG2, which is a turnover of 5-10 mol P i /s per mol of ABCG2 without added substrates. This basal activity of ABCG2 was stimulated by 2-2.5-fold, up to 20 mol P i /s per mol of ABCG2 (8 μmol P i /min per mg of ABCG2), by the substrate drugs (see also below). It should be noted that the specific ABCG2 ATPase activity obtained with our purified and reconstituted protein is at least an order of a magnitude higher than those reported in previous publications [3, 5] .
Since the isolated high-activity ABCG2 preparation provides a unique possibility for functional studies, in the following experiments we examined further the characteristics of the ATPase activity of ABCG2. When the ATP concentration dependence of the ABCG2 ATPase activity was examined, we found that, similarly to that seen in cholesterol-loaded insect cell membrane vesicles [8] , a relatively high ATP concentration was required for a half-maximal ATPase activity (Supplementary Figure S4 at http://www.biochemj.org/bj/450/bj4500387add.htm). The K m values for ATP in cholesterol-containing E. coli lipid-based liposomes were 1.0 mM both in the absence and presence of the drug substrate quercetin. In cholesterol-loaded Sf9 membranes, this value was 0.8 mM. Figure 3 shows the ATPase activity of the purified and reconstituted ABCG2 protein measured as a function of various concentrations of several well-known compounds interacting with ABCG2. In these experiments, ABCG2 reconstitution was achieved with 0.5 mg/ml E. coli lipid and 0.11 mg/ml cholesterol, that is 30 mol % of cholesterol. Sodium orthovanadate, a general inhibitor of ABC transporters, fully inhibited the ATPase activity of the purified ABCG2. The IC 50 for vanadate was approximately 3 μM in the reconstituted system, somewhat lower than that 
published for ABCG2 in the original Sf9 membrane (20 μM).
Quercetin and nilotinib are transported ABCG2 substrates [16, 17] , and both significantly stimulated the ABCG2 ATPase activity in a similar concentration range in the reconstituted system as found previously in cholesterol-loaded insect cell membrane preparations [8] . A specific inhibitor of ABCG2, Ko143 [18] , fully inhibited ABCG2 ATPase activity with an IC 50 value (15 nM) similar to that observed in Sf9 membrane preparations. The monoclonal 5D3 anti-ABCG2 antibody is a conformation-sensitive reagent and the loss of 5D3 binding may refer to major structural alterations of ABCG2. It has been shown that the 5D3 antibody inhibits the function of the protein by reacting with an extracellular epitope and stabilizing it in an inactive conformation [19] . In the present study we showed that the 5D3 antibody also effectively inhibited the ATPase activity of the purified and reconstituted ABCG2 at very low concentrations. These results indicate that the major features of the ABCG2 ATPase were preserved in the purified and reconstituted protein preparation.
Transport activity of the purified and reconstituted ABCG2
The ABCG2 protein directly utilizes the energy of ATP hydrolysis for transporting various compounds across the cell membrane. Although drug stimulation of ATPase activity indicates ongoing drug transport, it is important to show the substrate transport directly. In order to examine whether the transport activity of the purified and reconstituted ABCG2 was retained, the protein was reconstituted into cholesterol-enriched brain lipid liposomes by a standard multistep proteoliposome preparation (see the Experimental section). ABCG2 transport activity was examined by determining ATP-dependent radiolabelled methotrexate uptake into the proteoliposomes. Figure 4 shows a detectable ATP-dependent and Ko143-sensitive uptake of 3 H-methotrexate into the ABCG2 proteoliposomes. These results also indicate that a (currently undetermined) fraction of the ABCG2 molecules are in an insideout orientation in the reconstituted proteoliposomes.
Effects of bile acids on the ATPase activity of purified and reconstituted ABCG2
We have found previously that bile acids significantly decrease the basal ATPase activity of human ABCG2 expressed in insect cell membranes, especially when these membranes are enriched in cholesterol, whereas the same bile acid concentrations do not alter the maximum turnover of ABCG2 obtained with different transported substrates (Á. Telbisz and Cs.Özvegy-Laczka, unpublished work). We investigated whether bile acids have similar effects on the activity of the purified and reconstituted ABCG2. Since the activity of the purified and reconstituted ABCG2 protein also depends on the lipid composition (see above), we used proteoliposomes containing brain lipids supplemented with cholesterol, providing an environment in which both the basal and substrate-stimulated activities are typically high.
As shown in Figure 5 (A), we found that bile acids and their derivatives (glycocholate, taurocholate, cholic acid or CHAPS) decreased the basal ABCG2 ATPase activity without significantly affecting the substrate stimulation of this ATP hydrolysis. We should note that the applied concentrations of bile acids are well below their critical micellar concentration values (5-20 mM for different species). In Figure 5 (B) we demonstrate the concentration dependence of the effect of cholic acid in this system. As shown, for up to 1 mM of cholic acid there is practically no change in the substrate-stimulated ABCG2 ATPase activity, whereas the basal ATPase activity is strongly reduced. As a consequence, similarly to that found in the cholesterol-loaded insect cell membrane preparation, in the presence of bile acids, the ratio of substrate-stimulated over basal ABCG2 ATPase activity is greatly increased. These results indicate that the basal ABCG2 ATPase activity has a different sensitivity to bile acids, and suggest that this basal activity is mostly independent of the drug substrateinduced ATPase cycle (see the Discussion section). 
Characterization of the purified ABCG2-R482G variant
ABCG2 Arg 482
variants have grossly altered substrate, cholesterol and bile acid interactions when expressed in Sf9 cells ( [8, 13, 20] andÁ. Telbisz and Cs.Özvegy-Laczka, unpublished work). In the present study we also generated the N-terminally His 6 -tagged version of ABCG2-R482G and characterized its activity in reconstituted proteoliposomes.
The His 6 -ABCG2-R482G variant was successfully expressed in Sf9 cells, at a similar level to the wild-type ABCG2 protein (results not shown). The membrane isolation, as well as the purification and reconstitution of this variant, was also successful. By examining the ATPase activity of the purified and reconstituted ABCG2-R482G protein, we used E. coli lipids and cholesterol-containing liposomes and the simplified reconstitution protocol. As shown in Supplementary Figure S5 (at http://www.biochemj.org/bj/450/bj4500387add.htm), we found that, in accordance with results obtained in cholesterol-loaded Sf9 cell membrane preparations, the calculated turnover of the ATPase activity of the purified R482G variant was similar to or higher than that of the wild-type protein. We also found that the different substrate stimulation patterns seen in the original membrane environment were preserved in the purified proteins. In contrast with the wild-type protein, the ATPase activity of the R482G variant could be significantly stimulated by elacridar or imatinib [21] , inhibitors of the wild-type ABCG2, whereas quercetin or nilotinib had a similar stimulatory effect as in the case of wild-type ABCG2 (see Supplementary Figure S5) . Figure 6 summarizes the data obtained for the sterol modulation of the activity of the purified and reconstituted ABCG2-R482G protein. Although this variant was found to be practically insensitive to alterations in cholesterol levels in the insect membranes, surprisingly we found a major effect of cholesterol in the case of the purified protein. As depicted in Figure 6 (A), when reconstituted in E. coli lipids in the absence of cholesterol, the ATPase activity of the ABCG2-R482G protein was low and practically not stimulated by quercetin (or by other activating agents, results not shown). These experiments document that the addition of cholesterol to the liposomes resulted in a major increase in both the basal and the substrate-stimulated ATPase activity. Moreover, the addition of ergosterol or sitosterol had a similar activating effect ( Figure 6A ) as in the case of the wild-type ABCG2 ( Figure 2B) .
We also compared the effects of various cholesterol concentrations in the reconstituting lipid mixture on the ATPase activities of the wild-type ABCG2 and the R482G variant ( Figure 6B ). Although both variants require cholesterol for activation, there is a great difference in their activity at low cholesterol concentrations. Although the wild-type protein requires 30-40 mol % of cholesterol to reach full drug-stimulated activity, the R482G variant is already maximally active at 20 mol % of cholesterol. This difference may explain the findings in the insect cell membranes, where low levels of endogenous sterols may provide full activity for the R482G variant, but not for the wild-type ABCG2 protein.
The activity of the purified and reconstituted ABCG2-R482G protein was also modulated by the addition of bile acids (cholic acid, taurocholate or deoxycholate). The results obtained in the presence of 1 mM cholic acid are presented on Figure 6 (C), demonstrating the effect of bile acids on the R482G mutant of ABCG2. The basal ATPase activity of the R482G variant reconstituted in brain lipid with 40 mol % cholesterol was reduced by cholic acid, although to a lesser extent than that of the wild-type protein. The maximum level of drug stimulation in this variant was unaltered at the applied cholic acid concentration, similarly to the wild-type protein (see Figure 5 ).
DISCUSSION
Most of the functional data for membrane transporter proteins have been obtained by using intact tissues, cells or relevant membrane preparations. In all these cases, numerous additional factors (cellular trafficking, secondary modifications, membrane lipid environment and additional protein interactions) may significantly modify transporter activity. In the present study we attempted to achieve the isolation and reconstitution of human ABCG2, produced in a heterologous eukaryote (baculovirusinsect cell) expression system, allowing high level expression of the human protein in a functional form [10, 11] .
Purification, reconstitution and crystallization of eukaryotic large integral membrane proteins, especially those with numerous transmembrane regions, are not straightforward tasks. These proteins are usually sensitive to delipidation and their activity is easily lost during detergent-based purification processes. Certainly, until now, all purified and reconstituted ABCG2 preparations had significantly lower turnover rates than that observed in original membrane environments [3] [4] [5] .
In the present study we have demonstrated that an irreversible inactivation of ABCG2 during the purification process may be the consequence of the dissociation of the homodimers in the presence of certain detergents. Similar dimer dissociation problems have already been encountered in purification experiments for other ABC half-transporter proteins, e.g. TAP1/2 or BmrC/D [22, 23] . We found that in the case of ABCG2, applying excess lipids (shown to be beneficial in P-glycoprotein isolation [14] ) and a mild detergent, DDM, in membrane solubilization, preserved the homodimer and allowed the purification of a functional protein.
For the reconstitution of the ABCG2 transporter we applied various conditions for proteoliposome generation. We found that, in a brain lipid mixture, preferably enriched by extra cholesterol, a functional ABCG2 protein with similar substrate activation and inhibition characteristics as in cell membrane preparations can be obtained. The calculated turnover rate for the ABCG2 ATPase activity in our experiments (5-10 mol P i /s per mol of ABCG2 for basal, and 18-20 mol P i /s per mol of ABCG2 for substratestimulated ATPase) are similar to those obtained for highactivity reconstituted P-glycoprotein preparations [24] [25] [26] . These turnover numbers are approximately an order of magnitude higher than those obtained previously in purified and reconstituted ABCG2 preparations [3] [4] [5] and correspond to turnover rates calculated from transporter expression level and activity measured in cholesterol-loaded insect cell membrane preparations. We have also shown an ATP-dependent inhibitor-sensitive active drug transport by the purified and reconstituted ABCG2 protein.
The ABCG2 multidrug transporter preferentially extrudes drugs and xenobiotics recognized in the membrane lipid phase [1, [27] [28] [29] . This protein was suggested to be enriched in membrane lipid rafts [7] and both cholesterol [6] [7] [8] and cholesterol derivatives [30] have been shown to significantly modulate ABCG2 drug transport. The production of a reconstituted functional ABCG2 protein provides a new possibility to examine the direct effects of membrane lipid components on the activity of this transporter. Another multidrug transporter, P-glycoprotein (ABCB1) has already been characterized in detail regarding the influence of lipids on its drug transport activity [31] [32] [33] [34] [35] . It has been shown that P-glycoprotein has a strong preference for short or unsaturated fluid lipids [32] and that cholesterol increased the activity of the protein [31, 34, 36, 37] .
Moreover, with the same technology, mutant variants can also be purified and reconstituted, and their lipid requirements can be studied. We have shown in the present study that the purified wild-type ABCG2 protein shows the same basic cholesterol dependence as reported for ABCG2 in a cell membrane environment [8] . The cholesterol enrichment of the proteoliposomes to relatively high levels (up to 40 mol %) is required to obtain a high level of drug-stimulated ATPase activity or drug transport. In addition, we have shown that natural cell membrane lipid extracts, e.g. E. coli lipids or a mammalian brain lipid extract, provide a better lipid reconstitution protocol was used for these measurements, which were performed in duplicate and means + − S.D. are shown. *P < 0.01, significant difference between control and cholic acid-treated samples, Student's t test. environment for ABCG2 function than pure phosphatidylcholine or phosphatidylcholine/phosphatidylethanolamine mixtures.
An interesting finding, which could not be derived from studies on ABCG2 in cholesterol-loaded Sf9 cell membrane preparations, was the absolute cholesterol dependence of the activity of the ABCG2 protein, even in the case of the R482G variant, which was found to be insensitive to cholesterol loading of the Sf9 membranes [8] . We suggest that the explanation for this discrepancy is that even very low membrane sterol levels may fully activate the R482G transporter variant in the Sf9 membrane. Thus the R482G protein is not insensitive to cholesterol, but instead has a high affinity for cholesterol, exceeding that of the wildtype ABCG2 protein. It could also be shown that many sterol compounds can activate the purified and reconstituted ABCG2 protein, whereas such an activation was less pronounced in Sf9 membrane preparations.
As a conclusion, membrane cholesterol is an essential activator of ABCG2 function, and may also be a slowly transported substrate of this protein. Since cholesterol has an especially pronounced effect in the presence of transported drugs, either an allosteric co-activation or a co-transport of cholesterol and drugs may explain this phenomenon. The experiments of the present study cannot answer these questions, but the purified ABCG2 preparations may facilitate their exploration.
In the case of the ABCG2 protein a key functional assay is the measurement of a vanadate-sensitive substrate-stimulated ATPhydrolysis. In numerous studies a relatively high basal membrane ATPase activity for ABCG2 has been reported, which can be inhibited by specific inhibitors of ABCG2 [8] [9] [10] 38] . This basal activity was suggested to indicate either the presence of an endogenous substrate in the membrane preparations or a futile slippage activity of the transporter [39] [40] [41] . In fact, kinetic and mechanistic transport models suggested an important role of such a basal activity in the promiscuous drug recognition and transport properties of multidrug transporters [41] . According to the results from the present study, the isolated ABCG2 protein also has a relatively high basal ATPase activity, similar to that in cell membrane preparations. This basal activity is somewhat different in the R482G mutant variant, depending on the lipid environment and cholesterol, but may not be coupled to any transport activity.
Several bile acids or bile acid derivatives, at levels below their critical micelle concentrations, strongly reduce the basal ATPase activity, although this does not affect the ATPase's drugstimulated activities. These effects are also clearly present in the case of the purified and reconstituted ABCG2 protein, thus they reflect a direct interaction between lipids, bile acids and the transporter. As mentioned above, an interesting hypothesis suggests that the basal ATPase cycle of ABC transporters may facilitate binding of lower affinity drugs to the transporter and thereby increase the transport capacity for such compounds [39, 40] . Our experiments regarding the regulation of ABCG2 activity may support this concept by describing regulatory factors such as cholesterol and bile acids, modifying this futile ATPase activity. Further experiments regarding direct substrate and lipid/lipid derivative interactions with purified and reconstituted ABCG2 may help to answer these important questions.
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